Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–5 of 5 results
Advanced filters: Author: Philip J Hashkes Clear advanced filters

  • Substantial recent advances in the treatment of juvenile idiopathic arthritis have enabled the development of validated recommendations for the appropriate and safe use of several therapeutic agents. These recommendations, developed by an international group of experts, could prove a valuable resource for physicians treating these patients.

    • Philip J. Hashkes
    News & Views
    Nature Reviews Rheumatology
    Volume: 7, P: 377-378

  • Biologic agents are emerging as an important treatment for juvenile idiopathic arthritis (JIA), but the long-term safety of these therapies is a major concern and currently not completely understood. This Review examines available data for the safety of biologic therapies for JIA and details the serious adverse events associated with each agent as well as outlining the safety issues that need further study.

    • Philip J. Hashkes
    • Yosef Uziel
    • Ronald M. Laxer
    Reviews
    Nature Reviews Rheumatology
    Volume: 6, P: 561-571

  • 'Growing pains' is a term that has been applied for almost 200 years to describe and diagnose some forms of childhood limb pain. To date no clear mechanism has been identified. The authors present a thorough historical Review of the physical presentation, differential diagnoses, potential causative factors and management options for this phenomenon.

    • Robert M Lowe
    • Philip J Hashkes
    Reviews
    Nature Clinical Practice Rheumatology
    Volume: 4, P: 542-549